HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Akira Obana Selected Research

Drug Therapy (Chemotherapy)

3/2021Experience using mTOR inhibitors for subependymal giant cell astrocytoma in tuberous sclerosis complex at a single facility.
1/2015Antimicrobial action from a novel porphyrin derivative in photodynamic antimicrobial chemotherapy in vitro.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Akira Obana Research Topics

Disease

6Macular Degeneration (Age-Related Maculopathy)
01/2017 - 01/2002
5Cataract (Cataracts)
01/2021 - 09/2011
4Choroidal Neovascularization
03/2018 - 01/2002
3Tuberous Sclerosis (Bourneville's Disease)
03/2021 - 11/2018
2Glaucoma
11/2021 - 08/2020
2Polypoidal Choroidal Vasculopathy
02/2016 - 01/2008
2Phototoxic Dermatitis (Phototoxicity)
01/2004 - 01/2003
1Metabolic Syndrome (Dysmetabolic Syndrome X)
12/2021
1Astrocytoma (Pilocytic Astrocytoma)
03/2021
1Menstruation Disturbances
03/2021
1Oral Ulcer (Mouth Ulcer)
03/2021
1Diabetic Angiopathies (Diabetic Angiopathy)
11/2020
1Diabetic Retinopathy (Retinopathy, Diabetic)
11/2020
1Retinal Perforations
10/2020
1Open-Angle Glaucoma (Glaucoma, Open Angle)
08/2020
1Exfoliation Syndrome
08/2020
1Retinal Vein Occlusion
01/2020
1Hamartoma
05/2019
1Retinopathy of Prematurity (Retrolental Fibroplasia)
07/2018
1Infections
01/2015
1Myopia
09/2012
1Cicatrix (Scar)
01/2008
1Hemangioma (Angioma)
04/2004
1Capillary Hemangioma
04/2004
1von Hippel-Lindau Disease (von Hippel Lindau Disease)
04/2004
1Melanoma (Melanoma, Malignant)
01/2003

Drug/Important Bio-Agent (IBA)

5Macular PigmentIBA
01/2021 - 09/2011
3Carotenoids (Carotene)IBA
12/2021 - 01/2008
31-phenyl-3,3-dimethyltriazene (PDT)IBA
01/2004 - 01/2002
2Retinaldehyde (Retinal)IBA
11/2021 - 05/2019
2trans-sodium crocetinate (crocetin)IBA
03/2021 - 11/2018
2Advanced Glycation End ProductsIBA
11/2020 - 08/2020
2Ranibizumab (Lucentis)FDA Link
01/2020 - 01/2017
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2017 - 02/2016
2ZeaxanthinsIBA
09/2012 - 01/2008
2LuteinIBA
09/2012 - 01/2008
2Coloring Agents (Dyes)IBA
01/2004 - 01/2003
2Photosensitizing Agents (Photosensitizers)IBA
01/2004 - 01/2003
1AntioxidantsIBA
12/2021
1MTOR InhibitorsIBA
03/2021
1Syntex adjuvant formulationIBA
08/2020
1Fluorescein (Funduscein)FDA LinkGeneric
03/2018
1FibrinIBA
03/2018
1A-factor (Streptomyces)IBA
02/2016
1Verteporfin (Visudyne)FDA Link
01/2004
1Retinal Pigments (Pigments, Visual)IBA
01/2004
1Indocyanine Green (Cardio-Green)FDA LinkGeneric
12/2003
1IodidesIBA
01/2003
1SaltsIBA
01/2003
13- (4,5- dimethylthiazol- 2- yl)- 5- (3- carboxymethoxyphenyl)- 2- (4- sulfophenyl)- 2H- tetrazoliumIBA
01/2003

Therapy/Procedure

5Lasers (Laser)
07/2018 - 01/2002
5Photochemotherapy (Photodynamic Therapy)
10/2008 - 01/2002
2Drug Therapy (Chemotherapy)
03/2021 - 01/2015
2Intraocular Lens Implantation
01/2021 - 08/2014
2Light Coagulation
07/2018 - 04/2004
1Therapeutics
02/2016
1Intraocular Lenses (Intraocular Lens)
09/2011
1Semiconductor Lasers
01/2003